Taro Pharmaceutical
TARO
#5328
Rank
NZ$2.87 B
Marketcap
NZ$76.59
Share price
0.00%
Change (1 day)
8.50%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): NZ$0.99

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is NZ$2.17. In 2021 the company made an earnings per share (EPS) of NZ$0.07130 an increase over its 2020 EPS that were of NZ-$14.10.

EPS history for Taro Pharmaceutical from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$0.99
2021NZ$0.07130-100.51%
2020NZ-$14.10-222.45%
2019NZ$11.51-18.02%
2018NZ$14.0553.01%
2017NZ$9.18-55.95%
2016NZ$20.84-13.41%
2015NZ$24.0636.92%
2014NZ$17.5837.71%
2013NZ$12.7621.15%
2012NZ$10.5344.15%
2011NZ$7.31175.17%
2010NZ$2.66-48.8%
2009NZ$5.19
2005NZ$0.05348-91.89%
2004NZ$0.66-82.55%
2003NZ$3.7835.9%
2002NZ$2.7839.29%
2001NZ$2.00140.86%
2000NZ$0.8369.09%
1999NZ$0.49139.13%
1998NZ$0.2064.29%
1997NZ$0.12-36.36%
1996NZ$0.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.92 447.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.36 330.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-37.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.77-18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.13 135.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.12-48.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel